Heterogeneity of PD-L1 expression in primary tumors and paired lymph node metastases of triple negative breast cancer

BACKGROUND: Programmed cell death ligand 1 (PD-L1) is a potential predictive biomarker of the response to anti-PD-L1/anti- programmed cell death 1 (PD-1) therapy in multiple cancers, including triple negative breast cancer(TNBC). The purpose of this study was to investigate whether PD-L1 expression...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ming, Li, Anqi, Zhou, Shuling, Xu, Yan, Xiao, Yaoxing, Bi, Rui, Yang, Wentao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748959/
https://www.ncbi.nlm.nih.gov/pubmed/29291717
http://dx.doi.org/10.1186/s12885-017-3916-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748959/
https://www.ncbi.nlm.nih.gov/pubmed/29291717
http://dx.doi.org/10.1186/s12885-017-3916-y

Ejemplares similares